Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PET/CT-based IMRT After Induction Chemotherapy for HNSCC
NCT02047201Phase 2Completed
- Sponsor
- Lithuanian University of Health Sciences
- Start
- Jun 2013
- Primary completion
- Jan 2016
- Modality
- Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of docetaxel, Cisplatin micelle injection (HA132), fluorouracil in head and neck squamous cell carcinoma (HNSCC), sponsored by Lithuanian University of Health Sciences. Started Jun 2013; status: completed.
02
Drugs
docetaxelCisplatin micelle injection (HA132)fluorouracil
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT02047201.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02047201.